NCT06597292View on ClinicalTrials.gov

The VIS Opti-K Low Vision Aid Device Provides Vision Improvement.

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

December 30, 2026

Conditions
HyperopiaPresbyopia
Interventions
DEVICE

Vision improvement

Vision improvement for patients with refractive disorders (hyperopia and presbyopia)

Trial Locations (2)

78731

VIS, Inc., Austin

L4K 0J4

Clarity Eye Institute, Toronto

All Listed Sponsors
lead

VIS, Inc.

INDUSTRY

NCT06597292 - The VIS Opti-K Low Vision Aid Device Provides Vision Improvement. | Biotech Hunter | Biotech Hunter